Magnesium L-Threonate for Focus and Memory: Why We Use Glycinate Instead, For Now

Short answer: Magnesium L-threonate is marketed specifically on a cognition claim that magnesium glycinate never makes: that it crosses the blood-brain barrier more efficiently than other magnesium forms, raising brain magnesium levels and supporting memory and focus. That claim started with a real, well-known 2010 MIT/Tsinghua rat study, and it now has two human trials behind it — one small, funded by and written by the company that patented the compound, and one larger and better-designed but directly funded by the company that supplies the branded ingredient. Proco currently sells magnesium as glycinate, not threonate. That's not a dismissal of threonate's research — it's an honest read of where each form's evidence actually stands today. Glycinate has a longer and more independent record on absorption and tolerability, going back to the 1990s. Threonate's cognition claim is real, early, and worth watching — not yet worth building a product around. Here's the actual research behind that decision, trial by trial. For the general form-by-form comparison, see glycinate vs citrate vs threonate.

Evidence reviewed and corrected: September 2026.

The claim competitors are making, specifically

If you've shopped for a "brain-focused" magnesium, you've likely seen magnesium L-threonate marketed under the branded ingredient name Magtein — licensed to dozens of nootropic and cognitive-support brands. The pitch is narrower and more specific than most magnesium marketing: not "supports relaxation" or "supports sleep," but that threonate is the one magnesium form that meaningfully raises magnesium levels inside brain tissue, because the threonate molecule crosses the blood-brain barrier more efficiently than the compounds other magnesium forms (glycinate, citrate, oxide) are bound to.

That's a mechanistic claim, and it's a different one from what we look at when we evaluate magnesium glycinate for Magnesium Glycinate — glycinate's case rests on gut absorption and tolerability, not brain penetration, as we set out in why this form and what the absorption evidence shows. Threonate is playing a different game entirely, aimed squarely at focus and memory rather than sleep and calm. It deserves its own look on those terms.

Where the claim actually comes from: a 2010 rat study

The blood-brain-barrier story isn't marketing invention — it traces to a real, peer-reviewed study. In 2010, a team led by Guosong Liu, working across MIT and Tsinghua University (in a collaboration whose author list included Nobel laureate Susumu Tonegawa), published a study in Neuron testing whether raising brain magnesium could improve learning and memory.² Using magnesium-L-threonate in rats, the researchers reported enhanced learning, working memory and short- and long-term memory, improved pattern completion in aged rats, and a higher density of synaptic puncta in the hippocampus that correlated with the memory improvement.²

A compound that elevates brain magnesium and improves memory in rats is a genuinely promising starting point — it is not the same claim as it doing the same thing, at the same scale, in you.

That distinction matters because it's the actual sequence of events: an animal study established a real, mechanistically interesting effect, and a specific magnesium compound was patented around it by Liu's company, Neurocentria, Inc.³ None of that makes the rat data less real. It does mean the next question — does it work the same way in people — needed its own evidence, funded independently of the people who hold the patent. One point of housekeeping that most write-ups blur: the two human trials used different branded products. The 2016 trial tested MMFS-01, trademarked ClariMem by Neurocentria. The 2026 trial tested Magtein. Both are magnesium L-threonate; they are not the same commercial ingredient.

The first human trial: promising, small, and written by the patent holder

The first published human trial of magnesium-L-threonate for cognition came in 2016, from the same Guosong Liu, in the Journal of Alzheimer's Disease.⁴ It's worth knowing exactly what it did and didn't show:

Those are real, statistically significant cognitive results in a real randomized, placebo-controlled trial. Three things temper how much weight they should carry. First, the size: 44 analysed is a small trial by any standard, especially for a claim this specific. Second, the honest null the paper itself reports — sleep and anxiety effects were indeterminate. That matters because threonate is increasingly marketed on sleep as well as cognition, and the first human trial explicitly could not speak to it. Third, and most important: the study states that it "was funded by Neurocentria Inc.," the compound's patent holder, that the trial was "designed jointly by Neurocentria" and the contract research site, that Neurocentria conducted the statistical analysis for the cognitive and magnesium-status variables, and that "Neurocentria wrote the paper."⁴ That's not a reason to throw the result out — trials funded by an ingredient's owner can still be real science — but an analysis run and written by the company that profits from a positive result is a different evidentiary standard than an independently funded replication.

The newer trial: bigger, better-designed, and directly industry-funded

A second, more recent trial addresses some of that first study's weaknesses. Published online on 12 January 2026 in Frontiers in Nutrition (2025 volume 12), Lopresti and Smith ran a randomized, double-blind, placebo-controlled trial giving 2g of Magtein daily to 100 adults aged 18–45 with self-reported unsatisfying sleep, over 6 weeks.⁵ Larger sample, broader and younger population, both cognition and sleep outcomes:

That's a genuinely mixed result, reported honestly by the study itself: the primary composite moved, one working-memory sub-task moved, reaction time moved — but the Fluid Composite that contains that working-memory task did not, a separate reasoning test showed nothing at all, and objectively measured sleep did not improve despite one self-reported sleep measure doing so. This is a more credible design than the 2016 trial. It is not a clean sweep.

On independence, the published conflict-of-interest statement is explicit and stronger than "industry-adjacent": "This study received funding from Threotech Inc. Threotech Inc. also provided the IP in this study. The funder was involved in the conceptualisation of the study design and provided the investigational product for the study."⁵ The lead author also discloses running a contract research organisation that receives nutraceutical-industry funding. That doesn't make the trial's data wrong. It does mean both human data points behind this ingredient's cognition claim were funded by parties with a direct financial stake in a positive result.

Why we ship glycinate, not threonate — for now

We're not ruling threonate out. The mechanism has real rat data behind it, and the newer human trial is a step up from the first. But three things keep it out of Proco's range today, honestly stated:

1. The independent evidence base is longer for glycinate — but on different outcomes. Glycinate's case rests on absorption and tolerability data going back to the 1990s, replicated across research groups with no single company controlling the underlying patent. Its sleep trial base, by contrast, is one small 2025 RCT at p = 0.049 with a manufacturer-supplied supplement — no stronger than threonate's cognition base, and we're not going to pretend otherwise. What tips it is that glycinate's strongest claim (tolerability at a nightly dose) is independently established, whereas threonate's strongest claim (brain penetration mattering in humans) rests entirely on funded trials.

2. Proco's magnesium is built around glycinate's use case, not threonate's. Magnesium Glycinate — 275mg elemental magnesium from 2,500mg magnesium glycinate across three capsules — is positioned for sleep and nervous-system regulation. Threonate's claim is specifically cognitive, closer in spirit to Cognitive Support's territory than to a magnesium product built for winding down at night. And Cognitive Support is not a fair comparison either: eight of its ten actives sit inside a 255mg proprietary blend whose per-ingredient amounts our manufacturer does not disclose, so we can't put it head-to-head with a trial that used a known 2g dose. Adding threonate well would mean building it as a focus-and-memory ingredient at a stated dose, not slotting it in as "another magnesium."

3. We'd rather wait for independent replication than launch on trade-press momentum. One larger trial funded by the ingredient's supplier isn't the same evidentiary bar as an independently funded replication. This is the same posture we've taken with other ingredients under consideration but not added — the honest answer is "not yet," not "no." It's the same reasoning we've applied to what actually clears our bar.

If you specifically want the mechanism threonate is chasing — a magnesium form aimed at cognition rather than sleep — the most honest thing we can tell you today is that the early human evidence is real but not yet independently confirmed. If your goal is sleep or nervous-system support, glycinate is what we sell, and the trial evidence for magnesium and sleep in general is laid out in what a new trial actually found. If your goal is focus, the more useful reading is probably what actually helps brain fog, which is mostly not a magnesium question at all.

Bottom line

Threonate's cognition story isn't manufactured — it started with legitimate mechanistic research and now has real, if early and fully industry-funded, human trial support. That's a meaningfully different position from an ingredient with no science behind it at all. It's also not yet independently replicated, and neither is glycinate's sleep claim. We'd rather tell you honestly where both those lines sit than blur either one — overselling threonate's readiness, or overselling our own form's evidence to make the contrast look cleaner than it is.

This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Speak with a healthcare provider before starting any new supplement, especially if you take medication or have an existing health condition.

References

1. "Magnesium Glycinate vs. Citrate vs. Threonate: Which Form for Sleep, Stress, or Focus?" Proco. procohq.com
2. Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, Zhao X, Govindarajan A, Zhao MG, Zhuo M, Tonegawa S, Liu G. "Enhancement of learning and memory by elevating brain magnesium." Neuron, 2010;65(2):165–177. pubmed.ncbi.nlm.nih.gov
3. Neurocentria, Inc. Patent portfolio, magnesium threonate compositions and methods of use. patents.justia.com
4. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. "Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial." Journal of Alzheimer's Disease, 2016;49(4):971–990. pmc.ncbi.nlm.nih.gov
5. Lopresti AL, Smith SJ. "The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial." Frontiers in Nutrition, 2025;12 (published online 12 January 2026). pmc.ncbi.nlm.nih.gov
6. "Magtein magnesium L-threonate may boost cognitive performance and improve sleep." NutraIngredients, January 2026. nutraingredients.com

Related reading: Magnesium Glycinate vs. Citrate vs. Threonate and How Much Magnesium Is Too Much?

Want to know what's actually in what you take? Join the list — no spam, just it straight.